-
Nov 13, 2024 | 
endocrinenews.endocrine.org | Eric Seaborg |Kelly Horvath |Derek Bagley |Mark Newman
GLP-1 agonists are a cultural phenomenon. Celebrities and social media influencers hyping the drugs’ weight-loss success has led to demand outstripping supply, resulting in shortages for some patients who could benefit the most. High costs and limited insurance coverage have led patients to look for more affordable alternative sources. This success and notoriety have opened an attractive opportunity for imitators and quick-buck artists.
-
Oct 21, 2024 | 
endocrinenews.endocrine.org | Eric Seaborg |Derek Bagley |Mark Newman
Although polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-age women, the evidence base for diagnosis and treatment remains relatively weak for this “neglected” condition, according to the most recent international guideline.
-
Jun 3, 2024 | 
endocrinenews.endocrine.org | Eric Seaborg |Mark Newman
On June 3, during ENDO 2024 in Boston, “Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline” was officially released. While this new guideline suggests supplements might benefit specific populations and questions the need for testing, it also suggests that more research is needed to determine optimal levels for specific health benefits.
-
Mar 18, 2024 | 
endocrinenews.endocrine.org | Eric Seaborg |Derek Bagley |Colleen Williams |Mark Newman
Several recent studies have highlighted the importance of lean muscle mass versus the dangers of fat mass in children and adolescents — and suggest that adolescence could be a particularly important time to interrupt an individual’s trend toward the morbidities associated with obesity. Studies often rely on body mass index (BMI) alone as a measure of obesity, but BMI can be misleading because it does not differentiate lean mass from fat mass, according to Andrew O.
-
Nov 15, 2023 | 
endocrinenews.endocrine.org | Eric Seaborg |Mark Newman
The use of a clinical decision support tool can reduce the risk of hypoglycemia among older patients with type 2 diabetes, according to a new study spearheaded by the Endocrine Society. Many studies have shown that too often, physicians who are treating diabetes are so focused on achieving glycemic control goals that they overlook the risk of hypoglycemia in older adults with type 2 diabetes, according to Jeffrey B.
-
Sep 13, 2023 | 
endocrinenews.endocrine.org | Eric Seaborg |Mark Newman
Because endocrine dysfunction plays a prominent role in the development of steatotic liver disease, endocrinologists could play a larger role in its prevention and treatment, several specialists tell Endocrine News. To raise awareness of endocrinologists’ importance for this condition, ENDO 2023 included a session on endocrine targets in steatotic liver disease — and as a reflection of attendees’ interest, the room had to be enlarged to accommodate all those who wished to attend.
-
Sep 1, 2023 | 
kidneynews.org | Eric Seaborg
When rock icon Tina Turner died on May 24, 2023, at age 83, many obituaries highlighted her status as a patient with kidney disease. Her death brought new attention to her widely read blog post on a website for patients with kidney diseases, titled “My kidneys are victims of my elevated blood pressure” (1). Turner was diagnosed with hypertension in 1978 at approximately age 40, but said she “didn't care much about it.
-
Aug 8, 2023 | 
endocrinenews.endocrine.org | Kelly Horvath |Eric Seaborg |Mark Newman
Each year, the hottest tickets at ENDO are the various debates and ENDO 2023 was no exception when experts weighed in on the pros and cons of using vitamin D supplements in female patients at risk for osteoporotic fracture. One ENDO 2023 session that proved popular in June was “Is there a role for vitamin D supplementation for women at risk for osteoporotic fracture?” which was quite an important (not to mention exciting) debate.
-
Aug 7, 2023 | 
endocrinenews.endocrine.org | Eric Seaborg |Mark Newman
With the recent reexamination of how to consider race/ethnicity in medical treatment, many practitioners may feel confused about implementing such procedures. The ENDO 2023 symposium “Addressing Racial and Ethnic Disparities in Osteoporosis Care” provided attendees with an understanding of the impact of incorporating race/ethnicity in osteoporosis care and provide suggestions for treating their own patients.
-
May 2, 2023 | 
kidneynews.org | Eric Seaborg
The kidney community welcomed the announcement by the Health Resources and Services Administration (HRSA) of a “modernization initiative” that will overhaul the national system for procuring and allocating organs for transplantation.
